IOVANCE BIOTHERAPEUTICS, INC.
Ticker: 1425205
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 99.31+39.0% | 71.43+5.9% | 67.46+12.5% | 59.95+21.6% | 49.32-15.8% | 58.56+88.2% | 31.11+4220.8% | 0.72 |
| Total Income | 99.31+39.0% | 71.43+5.9% | 67.46+12.5% | 59.95+21.6% | 49.32-15.8% | 58.56+88.2% | 31.11+4220.8% | 0.72 |
| EXPENSES | ||||||||
| Expenditure | 151.22-0.8% | 152.47-6.1% | 162.36-6.5% | 173.73+1.9% | 170.55+15.5% | 147.62+11.0% | 133.02+12.3% | 118.44 |
| Tax | -1.37-104.5% | -0.67+72.2% | -2.41-221.1% | 1.99+208.2% | -1.84-21.1% | -1.52-4.1% | -1.46-3.5% | -1.41 |
| PROFIT | ||||||||
| PBT | -48.69+38.9% | -79.71+14.9% | -93.66+14.6% | -109.67+7.1% | -118.00-38.7% | -85.06+13.7% | -98.56+13.8% | -114.38 |
| Net Profit | -47.32+40.1% | -79.05+13.4% | -91.25+18.3% | -111.66+3.9% | -116.16-39.0% | -83.54+14.0% | -97.10+14.1% | -112.98 |
| KEY METRICS | ||||||||
| OPM % | -52.26%+47.73pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -47.64%+52.36pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.11+42.1% | -0.19+24.0% | -0.25+24.2% | -0.33+8.3% | -0.36-28.6% | -0.28+17.6% | -0.34+19.0% | -0.42 |
Corporate Events
Board MeetingIOVA
202610Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve e…
SEC Filing ↗